The ImmuneWatch Logo

White papers

SARS-CoV-2 Omicron

Omicron, the latest SARS-CoV-2 variant of concern is characterized by a large number of mutations. Here we evaluate the effect of these mutations on T-cell immunity by applying a T-cell receptor (TCR)/epitope interaction model.

Graph showing the predictions made for TCR/epitope binding of the SARS-CoV-2 Omicron variant.

Connect with us!

Business [at]

Privacy and cookie policy

Copyright © 2021 ImmuneWatch BV. ImmuneWatch is a registered trademark.

ImmuneWatch BV | BE0774.472.942 | Lange Gasthuisstraat 29-31, 2000, Antwerp, Belgium